The fact that the Telegraph is actually publishing stories like this shows there is increasing dissent among the media. (Patreon)

Revealed: Sir Patrick Vallance has £600,000 shareholding in firm contracted to develop vaccines

The UK's chief scientific adviser has a £600,000 shareholding in a drugs giant contracted to develop a Covid-19 vaccine for the Government, prompting claims of a potential conflict of interest. Sir Patrick Vallance, who also chairs the Government's expert advisory panel on vaccines, holds a deferred bonus of 43,111 shares in GlaxoSmithKline (GSK) worth £600,000 from his time as president of the multinational drug company, The Telegraph can reveal.